Speculation that GlobeImmune Inc. (Nasdaq: GBIM) may be an acquisition target sent shares of the biopharmaceutical soaring $1.25 to close at $3.30.
Acquisition speculation boosts GlobeImmune
June 17, 2016 at 16:33 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.